Puhong ZHANG - 张普洪's Publications

About Puhong ZHANG - 张普洪's Publications

Associate Director, The George Institute, China
  • Associate Professor, Faculty of Medicine, UNSW Sydney
  • Epidemiologist
  • PhD

  • Status-quo and factors of usage of maternal and child health related mobile phone application in Beijing and Hebei Province.

    China Health Education Date published:

  • Observational Registry of Basal Insulin Treatment in Patients with Type 2 Diabetes in China: Safety and Hypoglycemia Predictors

    Diabetes Technology & Therapeutics Date published:

  • Apolipoprotein status in type 2 diabetes mellitus and its complications

    Molecular Medicine Reports Date published:

  • Telmisartan and hydrochlorothiazide antihypertensive treatment in high sodium intake population

    Journal of Hypertension Date published:

  • Self-Monitoring of Blood Glucose in Patients with Type 2 Diabetes Before and After Initiating Basal Insulin Treatment in China

    Diabetes Technology & Therapeutics Date published:

  • Type 1 diabetes mellitus care and education in China: The 3C study of coverage, cost, and care in Beijing and Shantou

    Diabetes Research and Clinical Practice Date published:

  • Comparative effectiveness and safety of different basal insulins in a real-world setting

    Diabetes, Obesity and Metabolism Date published:

  • Observational Registry of Basal Insulin Treatment (ORBIT) in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic drugs: Real-life use of basal insulin in China

    Diabetes, Obesity and Metabolism Date published:

  • Mobile Device-Based Electronic Data Capture System Used in a Clinical Randomized Controlled Trial: Advantages and Challenges

    Journal of Medical Internet Research Date published:

  • ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus

    Clinica Chimica Acta Date published:

  • Comparative effectiveness and safety of three different basal insulins in patients with type 2 diabetes in a real world setting (ORBIT): a multicentre, prospective, registry study

    The Lancet Diabetes & Endocrinology Date published:

  • Effects of hyperlipidaemia on plasma apolipoprotein M levels in patients with type 2 diabetes mellitus: an independent case-control study

    Lipids in Health and Disease Date published:

  • OS 03-08 EFFICACY OF TELMISARTAN 40 MG (T40) AND HYDROCHLOROTHIAZIDE 25 MG (H25) MONOTHERAPY IN HIGH SODIUM INTAKE PATIENTS WITH MILD TO MODERATE HYPERTENSION (THAT STUDY)

    Journal of Hypertension Date published:

  • OS 26-03 MOBILE DEVICE BASED ELECTRONIC DATA CAPTURE SYSTEM IN PHARMACEUTICAL CLINICAL TRIAL

    Journal of Hypertension Date published:

  • Peak Systolic Velocity Measurements with Transcranial Doppler Ultrasound Is a Predictor of Incident Stroke among the General Population in China

    PLOS ONE Date published:

  • Association of Diabetic Microvascular Complications and Parameters of Obstructive Sleep Apnea in Patients with Type 2 Diabetes

    Diabetes Technology & Therapeutics Date published: